Home › Small Cell Lung Cancer
Small Cell Lung Cancer clinical trials recruiting in the U.S.
98 studies for Small Cell Lung Cancer are recruiting participants at sites across the United States.
Cities with the most studies
- Houston, TX26 studies
- Arlington, VA23 studies
- Boston, MA21 studies
- New York City, NY21 studies
- Los Angeles, CA20 studies
- Nashville, TN20 studies
- Orlando, FL15 studies
- Dallas, TX13 studies
- St. Louis, MO13 studies
- Cleveland, OH13 studies
- Detroit, MI12 studies
- Washington, DC12 studies
- Chicago, IL12 studies
- Baltimore, MD11 studies
- San Antonio, TX11 studies
- Philadelphia, PA10 studies
- Seattle, WA10 studies
- Atlanta, GA9 studies
- Durham, NC9 studies
- Grand Rapids, MI9 studies
- Tampa, FL9 studies
- Edison, NJ9 studies
- Queens, NY9 studies
- Indianapolis, IN9 studies
- Akron, OH8 studies
- Aurora, CO8 studies
- Columbus, OH8 studies
- Cedar Rapids, IA8 studies
- Miami, FL8 studies
- Omaha, NE8 studies
- Portland, OR8 studies
- Austin, TX7 studies
- Louisville, KY7 studies
- New Haven, CT7 studies
- Lexington, KY7 studies
- Cincinnati, OH7 studies
- West Valley City, UT7 studies
- Clifton, NJ6 studies
- Denver, CO6 studies
- Irving, TX6 studies
By state
- Alabama10 studies
- Arizona9 studies
- Arkansas5 studies
- California36 studies
- Colorado16 studies
- Connecticut9 studies
- District of Columbia5 studies
- Florida36 studies
- Georgia12 studies
- Illinois21 studies
- Indiana12 studies
- Iowa8 studies
- Kansas3 studies
- Kentucky15 studies
- Maryland19 studies
- Massachusetts22 studies
- Michigan26 studies
- Minnesota9 studies
- Missouri17 studies
- Nebraska10 studies
- New Jersey17 studies
- New Mexico3 studies
- New York31 studies
- North Carolina16 studies
- Ohio28 studies
- Oklahoma4 studies
- Oregon9 studies
- Pennsylvania15 studies
- South Carolina7 studies
- South Dakota3 studies
- Tennessee24 studies
- Texas41 studies
- Utah11 studies
- Virginia30 studies
- Washington13 studies
- Wisconsin11 studies
Recently updated studies
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07155174Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT02146170Prospective Multiomic Analysis in Small-Cell Lung Cancer
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07795411Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Oct 2, 2026 · NCT07509034The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Oct 2, 2026 · NCT04585750A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT03460977A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RecruitingPhase 1
Ages 19 and older · All sexes · Updated Oct 1, 2026 · NCT06586957177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07189871DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07472517Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07476287Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07226999A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07099898DESTINY-PANTUMOUR04
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07229313Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06047379A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07365241Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
RecruitingPhase 1
Ages 18 to 100 · All sexes · Updated Sep 22, 2026 · NCT07006727Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07278479A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07488676A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Sep 22, 2026 · NCT06066138Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05983432Study of Trilaciclib and Lurbinectidin
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05578326A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07730021A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07459634A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07407933From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.